Quick Answer
HARVARD BIOSCIENCE INC reported Revenue (ASC 606) of $86.55 million for fiscal year 2025.
HARVARD BIOSCIENCE INC Revenue (ASC 606) — Annual History
| Fiscal Year | Revenue (ASC 606) | YoY Change |
|---|---|---|
| 2025 | $86.55M | -8.1% |
| 2024 | $94.14M | -16.1% |
| 2023 | $112.25M | -1.0% |
| 2022 | $113.33M | -4.7% |
| 2021 | $118.90M | +16.5% |
| 2020 | $102.10M | -12.1% |
| 2019 | $116.18M | -3.8% |
| 2018 | $120.77M | — |
Quarterly Revenue (ASC 606)
| Quarter Ending | Revenue (ASC 606) | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $20.59M | -6.3% | +0.7% |
| June 30, 2025 | $20.45M | -11.5% | -6.1% |
| March 31, 2025 | $21.77M | -11.2% | -0.9% |
| September 30, 2024 | $21.97M | -13.4% | -4.9% |
| June 30, 2024 | $23.10M | -19.7% | -5.8% |
| March 31, 2024 | $24.51M | -18.2% | -3.4% |
| September 30, 2023 | $25.36M | -5.8% | -11.8% |
| June 30, 2023 | $28.76M | -1.5% | -4.1% |
- HARVARD BIOSCIENCE INC showed a decrease of -8.1% in Revenue (ASC 606) compared to the prior fiscal year.
- Over the 2018–2025 period, HARVARD BIOSCIENCE INC’s revenue (asc 606) has declined by 28.3% (from $120.77 million to $86.55 million).
- The most recent figure is from HARVARD BIOSCIENCE INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 13, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: